ResMed Inc (RMD)
Gross profit margin
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 3,054,970 | 2,655,300 | 2,355,660 | 2,024,310 | 1,839,100 |
| Revenue | US$ in thousands | 5,146,330 | 4,685,300 | 4,222,990 | 3,578,130 | 3,196,820 |
| Gross profit margin | 59.36% | 56.67% | 55.78% | 56.57% | 57.53% |
June 30, 2025 calculation
Gross profit margin = Gross profit ÷ Revenue
= $3,054,970K ÷ $5,146,330K
= 59.36%
The gross profit margin of ResMed Inc. demonstrates a fluctuating yet generally upward trend over the period from June 30, 2021, to June 30, 2025. Specifically, the margin was 57.53% as of June 30, 2021, which slightly declined to 56.57% by June 30, 2022, and further decreased to 55.78% by June 30, 2023. In the subsequent year, the gross profit margin recovered to 56.67% as of June 30, 2024, indicating a positive turnaround. By June 30, 2025, the margin experienced a more notable increase, reaching 59.36%, which represents the highest level within the analyzed period.
This pattern suggests that after a modest decline in gross profit margins over the initial two years, the company successfully improved its gross profitability going forward, ultimately achieving a more robust margin by mid-2025. The overall trend indicates resilience and potential operational efficiencies, along with improved cost management or pricing strategies contributing to the higher gross profit margin in the most recent year.
Peer comparison
Jun 30, 2025